Drake CG - Search Results

1

Tumor recognition and self-recognition induce distinct transcriptional profiles in antigen-specific CD4 T cells.

Getnet D, Maris CH, Hipkiss EL, Grosso JF, Harris TJ, Yen HR, Bruno TC, Wada S, Adler A, Georgantas RW, Jie C, Goldberg MV, Pardoll DM, Drake CG. Getnet D, et al. Among authors: drake cg. J Immunol. 2009 Apr 15;182(8):4675-85. doi: 10.4049/jimmunol.0803400. J Immunol. 2009. PMID: 19342643 Free PMC article.

2

Tumor immunology--towards a paradigm of reciprocal research.

Drake CG, Pardoll DM. Drake CG, et al. Semin Cancer Biol. 2002 Feb;12(1):73-80. doi: 10.1006/scbi.2001.0403. Semin Cancer Biol. 2002. PMID: 11926415 Review.

3

CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction.

Huang CT, Huso DL, Lu Z, Wang T, Zhou G, Kennedy EP, Drake CG, Morgan DJ, Sherman LA, Higgins AD, Pardoll DM, Adler AJ. Huang CT, et al. Among authors: drake cg. J Immunol. 2003 Apr 15;170(8):3945-53. doi: 10.4049/jimmunol.170.8.3945. J Immunol. 2003. PMID: 12682221

4

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Doody AD, Kovalchin JT, Mihalyo MA, Hagymasi AT, Drake CG, Adler AJ. Doody AD, et al. Among authors: drake cg. J Immunol. 2004 May 15;172(10):6087-92. doi: 10.4049/jimmunol.172.10.6087. J Immunol. 2004. PMID: 15128793 Free PMC article.

5

Bacteriolytic therapy can generate a potent immune response against experimental tumors.

Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA Jr, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B. Agrawal N, et al. Among authors: drake cg. Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15172-7. doi: 10.1073/pnas.0406242101. Epub 2004 Oct 7. Proc Natl Acad Sci U S A. 2004. PMID: 15471990 Free PMC article.

6

Role of LAG-3 in regulatory T cells.

Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA. Huang CT, et al. Among authors: drake cg. Immunity. 2004 Oct;21(4):503-13. doi: 10.1016/j.immuni.2004.08.010. Immunity. 2004. PMID: 15485628 Free article.

7

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ. Drake CG, et al. Cancer Cell. 2005 Mar;7(3):239-49. doi: 10.1016/j.ccr.2005.01.027. Cancer Cell. 2005. PMID: 15766662 Free PMC article.

8

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

Zhou G, Drake CG, Levitsky HI. Zhou G, et al. Among authors: drake cg. Blood. 2006 Jan 15;107(2):628-36. doi: 10.1182/blood-2005-07-2737. Epub 2005 Sep 22. Blood. 2006. PMID: 16179369 Free PMC article.

9

Mechanisms of immune evasion by tumors.

Drake CG, Jaffee E, Pardoll DM. Drake CG, et al. Adv Immunol. 2006;90:51-81. doi: 10.1016/S0065-2776(06)90002-9. Adv Immunol. 2006. PMID: 16730261 Review.

10

Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium.

Palapattu GS, Meeker A, Harris T, Collector MI, Sharkis SJ, DeMarzo AM, Warlick C, Drake CG, Nelson WG. Palapattu GS, et al. Among authors: drake cg. J Urol. 2006 Aug;176(2):813-8. doi: 10.1016/j.juro.2006.03.077. J Urol. 2006. PMID: 16813953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page